SILVER SPRING
Furoscix ReadyFlow cleared for edema in heart failure, CKD
- Sponsor
- MannKind Corporation $MNKD
- Drug
- Furoscix ReadyFlow · furosemide
- Indication
- Edema in adults with heart failure or chronic kidney disease
FDA approves MannKind's Furoscix ReadyFlow autoinjector for edema in adults with heart failure or chronic kidney disease.
What this means
Furoscix ReadyFlow is a pre-filled, single-use device that delivers the diuretic furosemide under the skin to help remove excess fluid. The FDA cleared this new delivery system for treating swelling in adults with heart failure or chronic kidney disease. This provides a simpler, needle-free option for patients who need this common medication outside of a clinic setting.
Drug Watch — recent news on Furoscix ReadyFlow
- MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost - Stocktwits
- MannKind Sees Early ReadyFlow Demand as Pediatric Afrezza Launch Gains Momentum - TradingView
- 10-pill warning for people on ramipril, amlodipine, furosemide or ibuprofen - North Wales Live
- 10-pill warning for people on ramipril, amlodipine, furosemide or ibuprofen - Cambridge News
- New HCPCS Billing Code Enables Medicare Benefit Billing of Lasix® ONYU When Furnished Incident to a Physician's Service - PR Newswire